share_log

荃信生物-B发布中期业绩 实现收入4491.9万元毛利3775.6万元

Quantum Hi-Tech Biological Co., Ltd. (B) released its mid-year results, achieving a revenue of 44.919 million yuan and a gross profit of 37.756 million yuan.

新浪港股 ·  Aug 15 17:37

China Bio-B (02509) released unaudited interim results for the six months ended June 30, 2024, with revenue of CNY 44.919 million and no revenue in the same period last year; gross profit of CNY 37.756 million; and research and development expenses of CNY 0.145 billion.

The announcement stated that the revenue came from authorization fees and R&D service fees for QX008N and QX004N authorized transactions, reflecting the group's strong R&D capabilities.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment